JX Luxventure Ltd (JXJT) News

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

JX Luxventure Limited Announced Financial Results for the Fiscal Year Ended December 31, 2023, achieving Profitability for the Full Year.

JX Luxventure Limited Announced Financial Results for the Fiscal Year Ended December 31, 2023, achieving Profitability for the Full Year. PR...

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

JX Luxventure Limited Announces Financial Results for The Six Months Ended June 30, 2023: The Company Achieved profitability in 2023 with Net Profit increase of $21,878,422 and Earnings Per Share increase of $25.89 From 2022

JX Luxventure Limited Announces Financial Results for The Six Months Ended June 30, 2023: The Company Achieved profitability in 2023 with Net...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

JX Luxventure Announced its new Collaboration with Hainan Airlines for Air-Ticket Sales, to Promote through the Company's Channels and Official Accounts incorporating ChatGPT-type Technology

JX Luxventure Announced its new Collaboration with Hainan Airlines for Air-Ticket Sales, to Promote through the Company's Channels and Official...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

JX Luxventure announces a new Artificial Intelligence initiative: USD1,000,000 Agreement with Tianjin Baixing Pharmaceutical Wholesale Co., Ltd. in connection with incorporating ChatGPT type technology for ERP platform

JX Luxventure announces a new Artificial Intelligence initiative: USD1,000,000 Agreement with Tianjin Baixing Pharmaceutical Wholesale Co., Ltd...

JX Luxventure Limited Cured Bid Deficiency and Continues Listing on Nasdaq; Scheduled Hearing Cancelled

JX Luxventure Limited Cured Bid Deficiency and Continues Listing on Nasdaq; Scheduled Hearing Cancelled PR Newswire HAIKOU, China, May 24, 2023...

Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 20-F/A (Amendment...

JX Luxventure Limited Reported a 35% Increase in Revenue Reaching $79.90 Million for the Fiscal Year Ended December 31, 2022

JX Luxventure Limited Reported a 35% Increase in Revenue Reaching $79.90 Million for the Fiscal Year Ended December 31, 2022 PR Newswire HAIKOU...